Ensysce Biosciences (ENSC) Institutional Ownership $0.59 -0.06 (-9.20%) (As of 11/21/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Ensysce Biosciences (NASDAQ:ENSC)CurrentInstitutional OwnershipPercentage5.63%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$236.04KNumber ofInstitutional Sellers(last 12 months)0 Get ENSC Insider Trade Alerts Want to know when executives and insiders are buying or selling Ensysce Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENSC Institutional Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Ensysce Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Anson Funds Management LP983,518$236K0.0%N/A11.151% 11/15/2023 Sabby Management LLC96,973$134K0.1%-69.9%3.079% 8/14/2023 Anson Funds Management LP36,261$65K0.0%N/A2.833% 5/1/2023Virtu Financial LLC13,433$65K0.0%N/A1.049% (Data available from 1/1/2016 forward) ENSC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENSC shares? During the previous two years, the following institutional investors and hedge funds held shares of Ensysce Biosciences shares: Anson Funds Management LP ($236K), and Sabby Management LLC ($134K), Virtu Financial LLC ($65K).Learn more on ENSC's institutional investors. What percentage of Ensysce Biosciences stock is owned by institutional investors? 5.63% of Ensysce Biosciences stock is owned by institutional investors. Learn more on ENSC's institutional investor holdings. Which institutional investors have been buying Ensysce Biosciences stock? The following institutional investors have purchased Ensysce Biosciences stock in the last 24 months: Anson Funds Management LP ($1.02M), and Virtu Financial LLC ($13.43K). How much institutional buying is happening at Ensysce Biosciences? Institutional investors have bought a total of 1,033,212 shares in the last 24 months. This purchase volume represents approximately $1.09M in transactions. Which Ensysce Biosciences major shareholders have been selling company stock? The following institutional investors have sold Ensysce Biosciences stock in the last 24 months: Sabby Management LLC ($225.33K). How much institutional selling is happening at Ensysce Biosciences? Institutional investors have sold a total of 225,325 shares in the last 24 months. This volume of shares sold represents approximately $310.95K in transactions. Related Companies ESLA Major Shareholders ICCC Major Shareholders LTRN Major Shareholders ACST Major Shareholders PMN Major Shareholders LIAN Major Shareholders SRZN Major Shareholders KALA Major Shareholders RNXT Major Shareholders CTXR Major Shareholders This page (NASDAQ:ENSC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENSC Stock Alerts